US spends $275M more on Eli Lilly's Covid mAb as about half of supplies have been administered so far

Zachary Brennan

Senior Editor

Eli Lilly said Wednesday that the US government has re-upped its supply of the Covid-19 treatment bebtelovimab, which is the last monoclonal antibody or mAb …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

US spends $275M more on Eli Lilly's Covid mAb as about half of supplies have been administered so far

Zachary Brennan

Senior Editor

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

US warns drugmakers against misrepresenting cost of imported products

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

US spends $275M more on Eli Lil­ly's Covid mAb as about half of sup­plies have been ad­min­is­tered so far

Senior Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

US spends $275M more on Eli Lilly's Covid mAb as about half of supplies have been administered so far